A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
for Pulmonary Hypertension Due to Lung Disease (Disorder)
Sites in Bend +4 more locations
Sponsor: Liquidia Technologies, Inc.
Sex: All·Age: 18 - 80
Code: NCT07285655·Phase 3·Recruiting·Listed Dec 2025